GetTopicDetailResponse(id=59ad2914473, topicName=免疫耐受期, introduction=免疫耐受期, content=null, image=null, comments=0, allHits=911, url=https://h5.medsci.cn/topic?id=29144, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=63044, tagList=[TagDto(tagId=63044, tagName=免疫耐受期)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2245730, encodeId=d2e72245e3013, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=59ad2914473' target=_blank style='color:#2F92EE;'>#免疫耐受期#</a>, objectTitle=【會(huì)議擷萃】耿嘉蔚教授：慢乙肝免疫耐受期診療進(jìn)展及臨床研究, objectType=article, longId=857033, objectId=b7dd85e03310, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=b7dd85e03310, replyNumber=0, likeNumber=53, createdTime=2024-12-31, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b7dd85e03310, moduleTitle=【會(huì)議擷萃】耿嘉蔚教授：慢乙肝免疫耐受期診療進(jìn)展及臨床研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b7dd85e03310)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212245, encodeId=f80d221224551, content=<a href='/topic/show?id=59ad2914473' target=_blank style='color:#2F92EE;'>#免疫耐受期#</a> <a href='/topic/show?id=40a21153043b' target=_blank style='color:#2F92EE;'>#EASL2024#</a> <a href='/topic/show?id=f17f116004a9' target=_blank style='color:#2F92EE;'>#HBV相關(guān)肝臟疾病#</a>, objectTitle=【EASL2024速遞】薈萃分析：免疫耐受期和灰區(qū)患者有較高的HBV相關(guān)肝臟疾病發(fā)生風(fēng)險(xiǎn), objectType=article, longId=828161, objectId=571182816126, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240619/1718795464407_5579292.jpg, objectUrl=/article/show_article.do?id=571182816126, replyNumber=0, likeNumber=132, createdTime=2024-06-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=571182816126, moduleTitle=【EASL2024速遞】薈萃分析：免疫耐受期和灰區(qū)患者有較高的HBV相關(guān)肝臟疾病發(fā)生風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=571182816126)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2209749, encodeId=e91c2209e49b1, content=<a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治療#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=59ad2914473' target=_blank style='color:#2F92EE;'>#免疫耐受期#</a>, objectTitle=專家論壇｜王艷：免疫耐受期HBV感染者抗病毒治療的臨床爭議, objectType=article, longId=829489, objectId=ceea8294898a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240613/1718271296701_1608702.png, objectUrl=/article/show_article.do?id=ceea8294898a, replyNumber=0, likeNumber=117, createdTime=2024-06-13, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ceea8294898a, moduleTitle=專家論壇｜王艷：免疫耐受期HBV感染者抗病毒治療的臨床爭議, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ceea8294898a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207438, encodeId=bb83220e43809, content=<a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=59ad2914473' target=_blank style='color:#2F92EE;'>#免疫耐受期#</a>, objectTitle=【EASL2024速遞】慢性HBV感染免疫耐受期患者轉(zhuǎn)為免疫活動(dòng)期的5年累積發(fā)生率達(dá)38%，肝臟相關(guān)不良事件風(fēng)險(xiǎn)增加, objectType=article, longId=827182, objectId=39bc82e1828d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717044921581_5579292.png, objectUrl=/article/show_article.do?id=39bc82e1828d, replyNumber=0, likeNumber=128, createdTime=2024-05-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=39bc82e1828d, moduleTitle=【EASL2024速遞】慢性HBV感染免疫耐受期患者轉(zhuǎn)為免疫活動(dòng)期的5年累積發(fā)生率達(dá)38%，肝臟相關(guān)不良事件風(fēng)險(xiǎn)增加, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=39bc82e1828d)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
